2026 Geromedicine Conference | Mr Lin Yi, Abinopharm, Inc.

Watch the presentation by Mr Lin Yi, CEO of Abinopharm, Inc., at the NUS Academy for Healthy Longevity’s 2026 Geromedicine Conference. This presentation explores the industrial manufacturing process for ergothioneine, a naturally occurring compound that has attracted interest in nutrition, cellular protection, and healthy longevity research. Mr Lin Yi discusses the considerations involved in producing ergothioneine at scale, including manufacturing approaches, process development, quality control, and the broader requirements for translating scientific interest into reliable industrial applications. The session offers insights into the intersection of biomanufacturing, nutrition, biotechnology, and geromedicine, highlighting the role of scalable production processes in supporting further research and potential applications related to healthy ageing and healthspan. The 2026 Geromedicine Conference brings together researchers, clinicians, entrepreneurs, and industry experts to explore advances in geroscience, geromedicine, and evidence-informed approaches to promoting healthy longevity. #Geromedicine #HealthyLongevity #Ergothioneine #Biomanufacturing #Biotechnology #NutritionScience #CellularHealth #HealthyAgeing #Healthspan #Geroscience #Abinopharm #NUSMedicine #NUSAcademyForHealthyLongevity